Therapeutic efficacy and mechanism of water-soluble extracts of Banxiaxiexin decoction on BALB/c mice with oxazolone-induced colitis

Experimental and Therapeutic Medicine

Volumn 8, Issue 4, 2014, Pages 1201-1204

  Wang, Xuewei ^a   Yang, Jinghui ^a   Cao, Qin ^a   Tang, Jianmin ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Banxiaxiexin decoction; Interleukin 13; Interleukin 5; Oxazolone; Ulcerative colitis

Indexed keywords

BAN XIA XIE XIN EXTRACT; BETA ACTIN; COPTIS RHIZOME EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; INTERLEUKIN 13; INTERLEUKIN 5; JUJUBE EXTRACT; OXAZOLONE; PINELLIA EXTRACT; PLANT EXTRACT; SALAZOSULFAPYRIDINE; SCUTELLARIA BAICALENSIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY SCORE; DRUG EFFICACY; HISTOPATHOLOGY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MRNA EXPRESSION ASSAY; NONHUMAN; RECTUM HEMORRHAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 84906486715     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1890     Document Type: Article

References (16)

1. Lee HJ, Jung ES, Lee JH, et al: Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis. Hepatogastroenterology 59: 1415-1420, 2012.
2. Manz M, Vavricka SR, Wanner R, et al: Therapy of steroid-resistant inflammatory bowel disease. Digestion 86 (Suppl 1): 11-15, 2012.
3. Taba Taba Vakili S, Taher M and Ebrahimi Daryani N: Update on the management of ulcerative colitis. Acta Med Iran 50: 363-372, 2012.
4. Sutherland LR, May GR and Shaffer EA: Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Inter Med 118: 540-549, 1993.
5. Bensoussan M, Jovenin N, Garcia B, et al: Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey. Gastroenterol Clin Biol 30: 14-23, 2006.
6. Xu G: Treatment of reflux laryngopharyngitis with modified Banxia Xiexin Tang (Pinellia decoction for draining the heart)-a report of 40 cases. J Tradit Chin Med 26: 127-131, 2006.
7. Health NIO: Guide for the care and use of laboratory animals. National Academies, National Academy Press, 1985.
8. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS and Strober W: Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13 producting NK-T cells. Immunity 17: 629-638. 2002.
9. Wirtz S, Neufert C, Weigmann B and Neurath MF: Chemically induced mouse models of intestinal inflammation. Nat Protoc 2: 541-546, 2007.
10. Ali SA and Alman B: RNA extraction from human articular cartilage by chondrocyte isolation. Anal Biochem 429: 39-41, 2012.
11. Bouma G and Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521-533, 2003.
12. Fuss IJ, Neurath M, Boirivant M, et al: Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157: 1261-1270, 1996.
13. Kakazu T, Hara J, Matsumoto T, et al: Type 1 T-helper cell predominance in granulomas of Crohn's disease. Am J Gastroenterol 94: 2149-2155, 1999.
14. Lampinen M, Carlson M, Hakansson LD and Venge P: Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59: 793-805, 2004.
15. Michail S and Abernathy F: A new model for studying eosinophil migration across cultured intestinal epithelial monolayers. J Pediatr Gastroenterol Nutr 39: 56-63, 2004.
16. Wang A, Fernando M, Leung, G, Phan V, Smyth D and McKay DM: Exacerbation of oxazolone colitis by infection with the helminth Hymenolepsis diminuta: involvement of IL-5 and eosinophils. Am J Pathol 177: 2850-2859, 2010.